Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.
Al Rizzo, MD, CMO of the American Lung Association, discusses some of the biggest challenges and questions raised on lung health during the coronavirus pandemic.
Amy S. Paller, MD, principal investigator of the phase 3 LIBERTY AD PEDS trial, discusses the add-on biologic's benefit for young patients and potential as a pediatrc allergic therapy.
Dr. Kaneko, a cardiac surgeon at Brigham and Women's Hospital, breaks down a trio of studies he was associated with from ACC.20, including a look into PLO FLOW TAVR, the July Effect, and alternative …
Ralph Sacco, MD, chairman of the Department of Neurology and Olemberg Family Chair in Neurological Disorders Miller Professor of Neurology at the University of Miami, discusses advances in stroke car…
A discussion on the state of rare disease with Sika Dunyoh, Director of Education Programs at the National Organization of Rare Disorders, for Rare Disease Day 2020.
A discussion on prescribing bempedoic acid in a real-world setting with steering committee chair Christie Ballantyne, MD, chief of Cardiology at Baylor College of Medicine.
David Lee, MD, discusses barbershop initiatives, their effectiveness, applicability in a real-world setting, and how they impact the health of a community as a whole.
Discussing recent TAVR news with Tsuyoshi Kaneko, MD, surgical director and director of outcomes research in the Structural Heart Program at the Brigham and Women's Hospital.
Michael Spigler, vice president of Patient Services and Kidney Disease Education for the American Kidney Fund, talks about the challenges and future of nephrology during Kidney Week.
A conversation with Deepak Bhatt, MD, MPH, discussing the most impactful advances in cardiology in 2019 and what he sees as the most important advances in the past decade as 2019 comes to a close.
Edmund Tsui, MD, social media editor for Ophthalmology, discusses some of the common pitfalls and advantages in the manner some physicians and clinicians navigate social media.
Dr. George Bakris, of the University of Chicago, discusses the impact of canagliflozin approval and how it impacts the current treatment of diabetic kidney disease.
Disclaimer: The podcast and artwork embedded on this page are the property of HCPLive.com. This content is not affiliated with or endorsed by eachpod.com.